Death By 1,000 Cuts: How Republicans Can Still Alter Your Coverage image

Kaiser Health News, April 10, 2017
Jay Hancock, quoting Rachel E. Sachs (Academic Fellow Alumna)


Read the full article

From the article:

“It’s the single-biggest problem facing the exchanges,” said Rachel Sachs, a health law professor at Washington University in St. Louis. “That would make insurers not only exit tomorrow but also not want to offer plans in 2018.”

Read more here!

biotechnology fda health care finance health care reform health law policy pharmaceuticals rachel sachs regulation